Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$761M |
| 3 |
Apple
AAPL
|
+$685M |
| 4 |
Amazon
AMZN
|
+$507M |
| 5 |
Cigna
CI
|
+$391M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$741M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$651M |
| 3 |
Praxair Inc
PX
|
+$555M |
| 4 |
COL
Rockwell Collins
COL
|
+$293M |
| 5 |
CA, Inc.
CA
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.02% |
| 2 | Financials | 15.32% |
| 3 | Healthcare | 15.13% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Communication Services | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Biogen
BIIB
$34.7B
| $815M | 0.25% |
2,713,577
+144,464
| +6% | +$46.1M |
2013 Q2
22 quarters
|
|
77
American Express
AXP
$211B
| $807M | 0.25% |
8,486,121
+459,983
| +6% | +$48.1M |
2013 Q2
22 quarters
|
|
78
TJX Companies
TJX
$162B
| $792M | 0.24% |
17,734,026
+1,297,338
| +8% | +$65.6M |
2013 Q2
22 quarters
|
|
79
Simon Property Group
SPG
$66.1B
| $790M | 0.24% |
4,712,315
+507,345
| +12% | +$90.7M |
2013 Q2
22 quarters
|
|
80
DELISTED
Walgreens Boots Alliance
WBA
| $787M | 0.24% |
11,529,136
+834,241
| +8% | +$64.7M |
2013 Q2
22 quarters
|
|
81
United Parcel Service
UPS
$82.5B
| $780M | 0.24% |
8,008,476
+585,738
| +8% | +$63.5M |
2013 Q2
22 quarters
|
|
82
Danaher
DHR
$162B
| $775M | 0.24% |
8,490,616
+657,843
| +8% | +$59.7M |
2013 Q2
22 quarters
|
|
83
Duke Energy
DUK
$94.3B
| $771M | 0.24% |
8,951,045
+750,534
| +9% | +$63.9M |
2013 Q2
22 quarters
|
|
84
GE Aerospace
GE
$327B
| $771M | 0.24% |
21,288,255
+1,301,023
| +7% | +$58.7M |
2013 Q2
22 quarters
|
|
85
Mondelez International
MDLZ
$81.7B
| $754M | 0.23% |
18,875,712
+1,928,429
| +11% | +$82.2M |
2013 Q2
22 quarters
|
|
86
Intuit
INTU
$86.2B
| $729M | 0.23% |
3,709,006
+118,956
| +3% | +$24.8M |
2013 Q2
22 quarters
|
|
87
Chubb
CB
$137B
| $726M | 0.22% |
5,631,484
+383,344
| +7% | +$49.5M |
2013 Q2
22 quarters
|
|
88
Becton Dickinson
BDX
$52.1B
| $722M | 0.22% |
3,288,798
+228,796
| +7% | +$53.1M |
2013 Q2
22 quarters
|
|
89
Goldman Sachs
GS
$257B
| $716M | 0.22% |
4,291,537
+411,700
| +11% | +$83.1M |
2013 Q2
22 quarters
|
|
90
Intuitive Surgical
ISRG
$152B
| $686M | 0.21% |
4,306,797
-51,516
| -1% | -$8.73M |
2013 Q2
22 quarters
|
|
91
Morgan Stanley
MS
$283B
| $672M | 0.21% |
16,970,026
+956,583
| +6% | +$41.7M |
2013 Q2
22 quarters
|
|
|
TFCFA
92
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $657M | 0.2% |
13,669,016
+860,913
| +7% | +$40.8M |
2013 Q3
21 quarters
|
|
93
PNC Financial Services
PNC
$86.4B
| $647M | 0.2% |
5,547,745
+323,714
| +6% | +$41.3M |
2013 Q2
22 quarters
|
|
94
Dominion Energy
D
$55.9B
| $646M | 0.2% |
9,056,270
+1,697,619
| +23% | +$124M |
2013 Q2
22 quarters
|
|
95
CSX Corp
CSX
$89.7B
| $644M | 0.2% |
31,160,406
+1,940,235
| +7% | +$44.6M |
2013 Q2
22 quarters
|
|
|
CELG
96
DELISTED
Celgene Corp
CELG
| $636M | 0.2% |
9,942,267
+787,638
| +9% | +$58.1M |
2013 Q2
22 quarters
|
|
97
Charter Communications
CHTR
$12.5B
| $631M | 0.2% |
2,218,112
+167,729
| +8% | +$52.6M |
2013 Q2
22 quarters
|
|
98
Colgate-Palmolive
CL
$74.4B
| $626M | 0.19% |
10,540,277
+768,550
| +8% | +$48.1M |
2013 Q2
22 quarters
|
|
99
Boston Scientific
BSX
$64.2B
| $599M | 0.19% |
16,982,002
+1,724,046
| +11% | +$62.5M |
2013 Q2
22 quarters
|
|
100
SLB Ltd
SLB
$73.4B
| $594M | 0.18% |
16,487,841
+1,125,484
| +7% | +$55.5M |
2013 Q2
22 quarters
|
|
Similar funds
Geode Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Geode Capital Management held 4,266 positions worth $323B, down 8.8% from $355B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management deployed $21.9B of net new capital in Q4 2018, opening 149 new positions and adding to 3,108 existing holdings. Its largest new stake was Linde: 6,406,340 shares worth $998M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dell, an estimated $92.5M trimmed.
- Geode Capital Management's largest Q4 2018 buy was Linde: 6,406,340 shares worth $998M.
- Geode Capital Management added most to Microsoft in Q4 2018, an estimated $761M increase.
- Geode Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $92.5M.
- Geode Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $741M.
- Geode Capital Management's ten largest holdings make up 17% of its $323B portfolio in Q4 2018.
- Geode Capital Management opened 149 new positions and closed 120 in Q4 2018.
- Geode Capital Management's portfolio value fell 8.8% quarter-over-quarter to $323B.
Based on Geode Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.